Amid the flurry of multi-billion dollar deals taking place in the pharmaceutical sector, strategic buyers within the middle market remain on the hunt for M&A opportunities as well. “A lot of these companies are looking to team up,” says Neil Kaufman of Abrams Fensterman, citing the recent joint venture between Ohr Pharmaceutical (Nasdaq: OHRP) and Cold Spring Harbor Laboratory that created DepYmed Inc.

 

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.